DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 08 · Volume 70 · 1993 DOI: 10.1055/s-008-40560

Review Article

  • 233
    Meyer, Dominique; Roberts, Harold R:

    A Tribute to Professor Jan J. Sixma Editor-in-Chief, Thrombosis and Haemostasis 1985 to 1993

  • 233
    Bergemann, Dieter:

    A Thank-you-note from the Publisher

  • 234
    Lüscher, Ernst F; Weber, Susanne:

    The Formation of the Haemostatic Plug – A Special Case of Platelet Aggregation

    • Original Articles

    Clinical Studies

  • 238
    Lindoff, Claes; Rybo, Göran; Åstedt, Birger:

    Treatment with Tranexamic Acid during Pregnancy, and the Risk of Thrombo-Embolic Complications

  • 241
    Branchi, Adriana; Rovellini, Angelo; Sommariva, Domenico; Gugliandolo, Angelo G; Fasoli, Angelo:

    Effect of Three Fibrate Derivatives and of Two HMG-CoA Reductase Inhibitors on Plasma Fibrinogen Level in Patients with Primary Hypercholesterolemia

  • 244
    Shigekiyo, T; Uno, Y; Kawauchi, S; Saito, S; Hondo, H; Nishioka, J; Hayashi, T; Suzuki, K:

    Protein S Tokushima: An Abnormal Protein S Found in a Japanese Family with Thrombosis

  • 247
    De Stefano, V; Mastrangelo, S; Schwarz, H P; Pola, P; Flore, R; Bizzi, B; Leone, G:

    Replacement Therapy with a Purified Protein C Concentrate during Initiation of Oral Anticoagulation in Severe Protein C Congenital Deficiency

  • 250
    Connelly, J B; Roderick, P J; Cooper, J A; Meade, T W; Miller, G J:

    Positive Association Between Self-Reported Fatty Food Consumption and Factor VII Coagulant Activity, a Risk Factor for Coronary Heart Disease, in 4246 Middle-Aged Men

  • 253
    Boisclair, Michael D; Lane, David A; Philippou, Helen; Sheikh, Sajila; Hunt, Beverley:

    Thrombin Production, Inactivation and Expression during Open Heart Surgery Measured by Assays for Activation Fragments Including a New ELISA for Prothrombin Fragment F1+2

  • 259
    Brister, S J; Ofosu, F A; Buchanan, M R:

    Thrombin Generation during Cardiac Surgery: Is Heparin the Ideal Anticoagulant?

  • 263
    Shigekiyo, Toshio; Ohshima, Tsutomu; Oka, Hirofumi; Tomonari, Akira; Azuma, Hiroyuki; Saito, Shiro:

    Congenital Histidine-Rich Glycoprotein Deficiency

  • 266
    Agnelli, Giancarlo; Cosmi, Benilde; Radicchia, Stefano; Veschi, Franca; Boschetti, Enrico; Lupattelli, Luciano; Rinonapoli, Emanuele; Nenci, Giuseppe G:

    Features of Thrombi and Diagnostic Accuracy of Impedance Plethysmography in Symptomatic and Asymptomatic Deep Vein Thrombosis

  • 270
    Morfini, M; Mannucci, P M; Tenconi, P M; Longo, G; Mazzucconi, M G; Rodeghiero, F; Ciavarella, N; De Rosa, V; Arter, A:

    Pharmacokinetics of Monoclonally-Purified and Recombinant Factor VIII in Patients with Severe von Willebrand Disease

    • Coagulation

  • 273
    Kappelmayer, Janos; Kunapuli, Satya P; Wyshock, Edward G; Colman, Robert W:

    Characterization of Monocyte-Associated Factor V

  • 281
    Tait, R C; Walker, Isobel D; Islam, S I A M; McCall, Frances; Conkie, J A; Wight, M; Mitchell, R; Davidson, J F:

    Protein C Activity in Healthy Volunteers - Influence of Age, Sex, Smoking and Oral Contraceptives

  • 286
    Tripodi, Armando; Chantarangkul, Veena; Arbini, Arnaldo A; Moia, Marco; Mannucci, Pier Mannuccio:

    Effects of Hirudin on Activated Partial Thromboplastin Time Determined with Ten Different Reagents

  • 289
    Elgue, G; Blombäck, M; Olsson, P; Riesenfeld, J:

    On the Mechanism of Coagulation Inhibition on Surfaces with End Point Immobilized Heparin

    • Fibrinolysis

  • 294
    Agnelli, Giancarlo; Pascucci, Claudia; Nenci, Giuseppe G; Mele, Antonio; Bürgi, Rolf; Heim, Jutta:

    Thrombolytic and Haemorrhagic Effects of Bolus Doses of Tissue-Type Plasminogen Activator and a Hybrid Plasminogen Activator with Prolonged Plasma Half-Life (K2tu-PA: CGP 42935)

  • 301
    Robbie, Linda A; Booth, Nuala A; Croll, Alison M; Bennett, Bruce:

    The Roles of α2-Antiplasmin and Plasminogen Activator Inhibitor 1 (PAI-1) in the Inhibition of Clot Lysis

  • 307
    Paoni, Nicholas F; Keyt, Bruce A; Refino, Canio J; Chow, Alice M; Nguyen, Hung V; Berleau, Lea T; Badillo, Julie; Peña, Luis C; Brady, Kevin; Wurm, Florian M; Ogez, John; Bennett, William F:

    A Slow Clearing, Fibrin-Specific, PAI-1 Resistant Variant of t-PA (T103N, KHRR 296-299 AAAA)

  • 313
    Refino, Canio J; Paoni, Nicholas F; Keyt, Bruce A; Pater, Cheryl S; Badillo, Julie M; Wurm, Florian M; Ogez, John; Bennett, William F:

    A Variant of t-PA (T103N, KHRR 296-299 AAAA) that, by Bolus, Has Increased Potency and Decreased Systemic Activation of Plasminogen

  • 320
    de Boer, A; Kluft, C; Gerloff, J; Dooijewaard, G; Günzler, W A; Beier, H; van der Meer, F J M; Cohen, A F:

    Pharmacokinetics of Saruplase, a Recombinant Unglycosylated Human Single-Chain Urokinase-Type Plasminogen Activator and Its Effects on Fibrinolytic and Haemostatic Parameters in Healthy Male Subjects

  • 326
    Lijnen, H R; Van Hoef, B; Smith, R A G; Collen, D:

    Functional Properties of p-Anisoylated Plasmin-Staphylokinase Complex

    • Platelets

  • 332
    Zucker, Marjorie L; Budd, Susan E; Dollar, Lawrence E; Chernoff, Steven B; Altman, Raul:

    Effect of Diltiazem and Low-Dose Aspirin on Platelet Aggregation and ATP Release Induced by Paired Agonists

  • 336
    Arvieux, J; Roussel, B; Pouzol, P; Colomb, M G:

    Platelet Activating Properties of Murine Monoclonal Antibodies to β2-Glycoprotein I

  • 342
    Shi, Wei; Chong, Beng H; Hogg, Philip J; Chesterman, Colin N:

    Anticardiolipin Antibodies Block the Inhibition by β2-Glycoprotein I of the Factor Xa Generating Activity of Platelets

  • 346
    Collins, Peter W; Macey, Marion G; Cahill, Mary R; Newland, Adrian C:

    Von Willebrand Factor Release and P-Selectin Expression Is Stimulated by Thrombin and Trypsin but not IL-1 in Cultured Human Endothelial Cells

  • 351
    Fricke, W A; Lamb, M A; Rastogi, S C:

    Standards for Assay of von Willebrand Factor Concentrates: A Collaborative Study

    • Scientific and Standardization Committee Communications

  • 357
    Zacharski, Leo R; Donati, Maria Benedetta; Rickles, Frederick R:

    Registry of Clinical Trials of Antithrombotic Drugs in Cancer: Second Report

  • 361
    Lane, D A; Olds, R J; Boisclair, M; Chowdhury, V; Thein, S L; Cooper, D N; Blajchman, M; Perry, D; Emmerich, J; Aiach, M:

    Antithrombin III Mutation Database: First Update

    • Letter to the Editor

  • 370
    de la Salle, C; Charmantier, J-L; Baas, M-J; Schwartz, A; Wiesel, M-L; Grunebaum, L; Cazenave, J-P:

    A Deletion Located in the 3′ Non Translated Part of the Factor IX Gene Responsible for Mild Haemophilia B

  • 371
    Arruda, Valder R; Annichino-Bizzachi, Joyce M; de Fatima Sonati, Maria; Costa, Fernando F:

    Factor VIII and IX Genes Polymorphisms in a Brazilian Black Population

  • 372
    Exner, Thomas; Dybkaer, Rene:

    International Sensitivity or Insensitivity Indexes for Calibrating Working Methods against a Reference Procedure

  • 373
    van den Besselaar, A M H P; Mannucci, P M; Lewis, S M:

    Rebuttal to the Letter by T. Exner and R. Dybkaer

  • 373
    Gareau, Raynald; Gagnon, Marie-Guylaine; Ayotte, Christiane; Chénard, Claire; Brisson, Guy R:

    rHuEPO lncreases Urinary Excretion of Fibrin Degradation Products in Haemodialysed Patients

  • 374
    Gruel, Y; Boizard-Boval, B; Wautier, J L:

    Further Evidence that Alpha-Granule Components such as Platelet Factor 4 Are Involved in Platelet-IgG-Heparin Interactions during Heparin-Associated Thrombocytopenia

  • 376
    Aoki, Nobuo:

    Clot Retraction Increases Clot Resistance to Fibrinolysis by Condensing α2-Plasmin Inhibitor Crosslinked to Fibrin